Charles River Laboratories (North Carolina) Completes the Acquisition of NewLab BioQuality AG

WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it has completed the acquisition of privately-held NewLab BioQuality AG (NewLab), a Dusseldorf, Germany-based provider of safety and quality control services to biopharmaceutical clients. NewLab joins Charles River Biopharmaceutical Services, which provides services to support the development and manufacture of biologics.

Back to news